These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17931085)

  • 1. Retreatment of chronic hepatitis C in previous non-responders and relapsers.
    Satoskar R; Jensen DM
    Expert Opin Pharmacother; 2007 Oct; 8(15):2491-503. PubMed ID: 17931085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin alpha 1 in combination with interferon alpha and ribavirin in chronic hepatitis C patients who are non-responders or relapsers to interferon alpha plus ribavirin.
    Abbas Z; Hamid SS; Tabassum S; Jafri W
    J Pak Med Assoc; 2004 Nov; 54(11):571-4. PubMed ID: 15623184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy.
    Moucari R; Ripault MP; Oulès V; Martinot-Peignoux M; Asselah T; Boyer N; El Ray A; Cazals-Hatem D; Vidaud D; Valla D; Bourlière M; Marcellin P
    J Hepatol; 2007 Apr; 46(4):596-604. PubMed ID: 17218037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retreatment options for patients with chronic hepatitis C].
    Hrstić I; Ostojić R; Vucelić B
    Acta Med Croatica; 2009 Dec; 63(5):417-22. PubMed ID: 20198901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group.
    Cavalletto L; Chemello L; Donada C; Casarin P; Belussi F; Bernardinello E; Marino F; Pontisso P; Gatta A; Alberti A
    J Hepatol; 2000 Jul; 33(1):128-34. PubMed ID: 10905596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retreatment strategies for the patients with HCV infection].
    Pawłowska M
    Przegl Epidemiol; 2005; 59(2):591-4. PubMed ID: 16190570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences].
    Roznovský L; Orságová I; Petrousová L; Mrázek J; Kloudová A; Kabieszová L; Kůrková J; Pospísek M
    Klin Mikrobiol Infekc Lek; 2010 Apr; 16(2):73-5. PubMed ID: 20503159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy.
    Wietzkebetaraun P; Meier V; Braun F; Ramadori G
    World J Gastroenterol; 2001 Apr; 7(2):222-7. PubMed ID: 11819764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis C.
    Dettmer RM; Reinus JF; Clain DJ; Aytaman A; Levendoglu H; Bloom AA; Isaacson MP; Spinnell M; Meyer D; Sarabanchong V; Zhang Y; Garcia-Carrasquillo RJ; Markowitz DD; Magun AM; Worman HJ
    Hepatogastroenterology; 2002; 49(45):758-63. PubMed ID: 12063985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: one year follow-up after 48 weeks of treatment.
    Aladağ M; Karasu Z; Wright H; Gürakar A
    Turk J Gastroenterol; 2006 Mar; 17(1):35-9. PubMed ID: 16830275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone.
    Milella M; Santantonio T; Pietromatera G; Maselli R; Casalino C; Mariano N; Genchi C; Pastore G
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):211-5. PubMed ID: 10379482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsers after combination therapy for chronic hepatitis C.
    Ahmed F; Jacobson IM
    Gastroenterol Clin North Am; 2004 Sep; 33(3):513-26, viii. PubMed ID: 15324941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment.
    Floreani A; Cazzagon N; Furlan P; Baldovin T; Egoue J; Antoniazzi S; Baldo V; Minola E
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):711-5. PubMed ID: 21654322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological relapse in chronic hepatitis C.
    Poordad FF; Flamm SL
    Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial.
    Pessôa MG; Cheinquer H; Almeida PR; Silva GF; Lima MP; Paraná R; Lacerda MA; Parise ER; Pernambuco JR; Pedrosa SS; Teixeira R; Sette H; Tatsch F
    Ann Hepatol; 2012; 11(1):52-61. PubMed ID: 22166561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy.
    Gelderblom HC; Zaaijer HL; Dijkgraaf MG; Van Der Meer J; Weegink CJ; Jansen PL; Beld MG; Reesink HW
    Scand J Gastroenterol; 2008; 43(7):857-69. PubMed ID: 18584525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C: retreatment of relapsers. An evidence-based approach.
    Cammà C; Craxì A
    Semin Gastrointest Dis; 2000 Apr; 11(2):115-21. PubMed ID: 10803635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection.
    Sagir A; Heintges T; Akyazi Z; Oette M; Erhardt A; Häussinger D
    Liver Int; 2007 Sep; 27(7):954-9. PubMed ID: 17696934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Myers RP; Poynard T
    Cochrane Database Syst Rev; 2002; (4):CD003617. PubMed ID: 12519606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.